Xpres Spa Group, Inc. XSPA
We take great care to ensure that the data presented and summarized in this overview for XpresSpa Group, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in XSPA
Top Purchases
Top Sells
About XSPA
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
Insider Transactions at XSPA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 11
2024
|
Gaelle Sandra Wizenberg Director |
BUY
Open market or private purchase
|
Direct |
1,201
+44.47%
|
$1,201
$1.65 P/Share
|
|
Sep 04
2024
|
Ezra Ernst President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+49.08%
|
-
|
|
May 07
2024
|
Gaelle Sandra Wizenberg Director |
BUY
Open market or private purchase
|
Direct |
199
+39.96%
|
$199
$1.85 P/Share
|
|
Apr 26
2024
|
Gaelle Sandra Wizenberg Director |
BUY
Open market or private purchase
|
Direct |
100
+50.0%
|
$100
$1.83 P/Share
|
|
Jan 08
2024
|
Suzanne A. Scrabis Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432
-9.46%
|
$432
$1.72 P/Share
|
|
Oct 31
2023
|
Suzanne A. Scrabis Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
432
-8.64%
|
$864
$2.14 P/Share
|
|
Jul 10
2023
|
Suzanne A. Scrabis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Jun 30
2023
|
Omar Haynes Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,963
-3.24%
|
$0
$0.2 P/Share
|
|
Jun 15
2023
|
Omar Haynes Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+33.27%
|
-
|
|
May 30
2023
|
Robert Weinstein Director |
BUY
Open market or private purchase
|
Direct |
25,000
+13.78%
|
$0
$0.25 P/Share
|
|
May 26
2023
|
Robert Weinstein Director |
BUY
Open market or private purchase
|
Direct |
25,000
+15.98%
|
$0
$0.25 P/Share
|
|
Mar 31
2023
|
Omar Haynes Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,412
-3.87%
|
$0
$0.36 P/Share
|
|
Dec 31
2022
|
Omar Haynes Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,083
-4.53%
|
$0
$0.39 P/Share
|
|
Dec 06
2022
|
Scott R Milford President & CEO |
BUY
Open market or private purchase
|
Direct |
22,950
+35.8%
|
$0
$0.54 P/Share
|
|
Dec 05
2022
|
Scott R Milford President & CEO |
BUY
Open market or private purchase
|
Direct |
5,800
+24.16%
|
$0
$0.51 P/Share
|
|
Dec 01
2022
|
Bruce Bernstein Director |
BUY
Open market or private purchase
|
Direct |
33,890
+4.17%
|
$0
$0.43 P/Share
|
|
Nov 30
2022
|
Bruce Bernstein Director |
BUY
Open market or private purchase
|
Direct |
16,110
+2.12%
|
$0
$0.4 P/Share
|
|
Oct 28
2022
|
Omar Haynes Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+49.86%
|
-
|
|
Jun 17
2022
|
Ezra Ernst President and CEO |
BUY
Open market or private purchase
|
Direct |
12,602
+35.8%
|
$0
$0.79 P/Share
|
|
Apr 20
2022
|
Robert Weinstein Director |
SELL
Open market or private sale
|
Direct |
45,000
-29.71%
|
$45,000
$1.06 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 30K shares |
|---|---|
| Open market or private purchase | 1.5K shares |
| Payment of exercise price or tax liability | 864 shares |
|---|